Anlon Healthcare Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The Anlon Healthcare Q2 results FY27 announcement is the next scheduled earnings event for Anlon Healthcare Ltd., a manufacturer of pharmaceutical excipients, active ingredients and speciality chemicals supplying formulation and nutraceutical customers. The stock traded at Rs 16.05 on the NSE on 9 September 2026, up 2.82% from the previous close of Rs 15.61, about 7.1% below its 52-week high of Rs 17.28 and 73.3% above its 52-week low of Rs 9.26.

What makes the Anlon Healthcare Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 52.20 crore of revenue and a profit of Rs 9.32 crore, while the most recent quarter on record, Q1 FY27, produced Rs 30.98 crore and a profit of Rs 4.80 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the Anlon Healthcare Q2 Results FY27 Date?

The Anlon Healthcare Q2 results date for FY27 is not confirmed. As of 9 September 2026, Anlon Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Anlon Healthcare Q2 results date becomes public through that filing rather than through any advance announcement.

The Anlon Healthcare Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Anlon Healthcare.

Anlon Healthcare Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the Anlon Healthcare Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Anlon Healthcare. The Anlon Healthcare Q2 results watchlist below is built from what the company has actually reported and disclosed.

The first is the alternating pattern. Anlon Healthcare's revenue has swung between roughly Rs 31 crore and Rs 55 crore in alternate quarters, with September 2025 and March 2026 both strong and June quarters weak, so the September base of Rs 52.20 crore is a demanding one.

The second is margin, which has held in a reasonably narrow band. Operating margin was 24.08% in Q1 FY27 against 26.32% in the September 2025 quarter, so the profit gap between those two periods came mostly from volume.

The third is order timing in excipients and speciality chemicals. Supply to formulation customers arrives in campaigns rather than evenly, which is the most likely explanation for the alternating revenue shape.

Check Anlon Healthcare Ltd. Live Fundamentals on the Univest Screener

Anlon Healthcare Q2 Results Preview: The Q1 FY27 Actuals It Builds On

Anlon Healthcare Ltd. reported revenue of Rs 30.98 crore in Q1 FY27, down 6.97% from Rs 33.30 crore in Q1 FY26, and a profit of Rs 4.80 crore at the net level, up 35.21% from Rs 3.55 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was down 44.10% over the March 2026 quarter figure of Rs 55.42 crore, and net profit was down 50.97% from Rs 9.79 crore in Q4 FY26. Operating margin stood at 24.08% in Q1 FY27 against 26.32% in the September 2025 quarter, which is the comparison the Anlon Healthcare Q2 results print will be read against.

Q2 FY26 Base: The Comparison Anlon Healthcare Q2 Results FY27 Must Beat

Anlon Healthcare Ltd. reported revenue of Rs 52.20 crore and a profit of Rs 9.32 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Anlon Healthcare Q2 results preview.

Net profit in that base quarter was above the Rs 4.80 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 52.20 crore sits above the Rs 30.98 crore of the June 2026 quarter, which frames how much sequential movement the Anlon Healthcare Q2 results print needs to show growth.

Anlon Healthcare Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	52.20	9.32
Q3 FY26 (Dec 2025)	35.58	5.15
Q4 FY26 (Mar 2026)	55.42	9.79
Q1 FY27 (Jun 2026)	30.98	4.80

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this Anlon Healthcare Q2 results preview uses.

Revenue across those four quarters ranged from Rs 30.98 crore to Rs 55.42 crore, and net profit from Rs 4.80 crore to Rs 9.79 crore. That spread is the honest context for the Anlon Healthcare Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape Anlon Healthcare Q2 Results FY27

The Anlon Healthcare Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Anlon Healthcare has already reported.

Campaign-Based Order Flow

Revenue of Rs 30.98 crore in June 2026 against Rs 55.42 crore in March 2026 is a swing of nearly half. Comparing consecutive quarters is therefore misleading, and only the year-on-year comparison against the same quarter is informative.

Customer Concentration and Approvals

Excipient and active ingredient supply depends on being qualified into a customer's formulation. Winning or losing a qualification changes revenue for several quarters, and it is disclosed in commentary rather than in the numbers.

Recent Listing and a Strong Run

The stock trades at Rs 16.05, close to its 52-week high of Rs 17.28 and well above its 52-week low of Rs 9.26, with a 14-day RSI of 71.91. Its listing history is short, so the moving averages cover a limited period.

Anlon Healthcare Q2 Results FY27: Share Price and Valuation Going Into the Print

Anlon Healthcare share price today is Rs 16.05 on the NSE, up Rs 0.44 or 2.82% from the previous close of Rs 15.61 on 9 September 2026, ahead of the Anlon Healthcare Q2 results announcement.

Metric	Value (8 September 2026)
NSE Symbol	AHCL
Current Market Price	Rs 16.05
52-Week High	Rs 17.28
52-Week Low	Rs 9.26
Market Capitalisation	Rs 827 crore
PE Ratio	24.30
Sector PE	37.99
PB Ratio	3.59
EPS (TTM)	Rs 0.64
Book Value per Share	Rs 3.95
Debt to Equity	0.19
Return on Equity	19.20%
50-Day Moving Average	Rs 15.11
200-Day Moving Average	Rs 13.96
RSI (14)	71.91

The stock trades above both its 50-day average of Rs 15.11 and its 200-day average of Rs 13.96, with a 14-day RSI of 71.91. None of this is a view on where the shares go once the Anlon Healthcare Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track Anlon Healthcare Ltd. live price and quarterly earnings updates.

What Investors Should Watch When Anlon Healthcare Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the Anlon Healthcare Q2 results print in proportion.

1. Revenue against the Rs 52.20 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 9.32 crore in that same quarter
3. Operating margin against 24.08% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Anlon Healthcare Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on Anlon Healthcare Q2 Results FY27

The Anlon Healthcare Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Anlon Healthcare Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the Anlon Healthcare Q2 results FY27 print faces a base of Rs 52.20 crore in revenue and a profit of Rs 9.32 crore, with the most recent quarter having delivered Rs 30.98 crore and a profit of Rs 4.80 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Anlon Healthcare, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on Anlon Healthcare Q2 Results FY27

What is the Anlon Healthcare Q2 results date for FY27?

Ans. The Anlon Healthcare Q2 results date for FY27 is not confirmed. Anlon Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the Anlon Healthcare Q2 results 2026 cover?

Ans. The Anlon Healthcare Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Anlon Healthcare Ltd. reports revenue, operating profit and net profit for that period, and the Anlon Healthcare Q2 results filing also carries the notes to the accounts.

What were the Anlon Healthcare Q1 FY27 results?

Ans. Anlon Healthcare Ltd. reported revenue of Rs 30.98 crore in Q1 FY27 and a profit of Rs 4.80 crore at the net level. Revenue was down 6.97% versus Q1 FY26 and net profit was up 35.21% from Rs 3.55 crore in Q1 FY26.

What were Anlon Healthcare Q2 FY26 results in the September 2025 quarter?

Ans. Anlon Healthcare Ltd. reported revenue of Rs 52.20 crore and a profit of Rs 9.32 crore in Q2 FY26. Operating margin was 26.32%. Those figures form the base for the Anlon Healthcare Q2 results FY27 comparison.

What are the main Anlon Healthcare Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The Anlon Healthcare Q2 results expectations centre on revenue against the Rs 52.20 crore base, net profit against a profit of Rs 9.32 crore, operating margin against 24.08% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is Anlon Healthcare share price today ahead of the Q2 earnings?

Ans. Anlon Healthcare share price is Rs 16.05 on the NSE as of 9 September 2026, up 2.82% from Rs 15.61. The stock is about 7.1% below its 52-week high of Rs 17.28 and 73.3% above its 52-week low of Rs 9.26, at a market capitalisation of Rs 827 crore.

Is Anlon Healthcare a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on Anlon Healthcare Ltd.. The stock trades at a price-to-book ratio of 3.59 with a return on equity of 19.20%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.